I have been diagnosed with diabetic retinopathy. The doctor recommends intravitreal injections over a few months. It's a ...
The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...
Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...
ThePrint on MSN8d
From cancer to diabetic retinopathy, how AIIMS is betting big on AI to aid in diagnosticsArogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...
US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...
Healthcare Asia on MSN3d
Saudi healthcare research centre to combat diabetic retinopathy in new partnershipThe collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...
Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has ...
Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...
Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...
DR was graded according to early Treatment Diabetic Retinopathy (ETDRS) criteria. Results: Of 199 subjects, 108 patients (54.3%) suffer from dry eye syndrome. Although dry eye syndrome was more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback